National and Kapodistrian University of Athens
Σχέση της υπολειπόμενης δραστικότητας των αιμοπεταλίων, μετά από φόρτιση με κλοπιδογρέλη, με το ενδοστεφανιαίο θρομβωτικό φορτίο και τη μυοκαρδιακή αιμάτωση σε ασθενείς με οξύ έμφραγμα του μυοκαρδίου
Abstract
dc:descriptionBackground: Despite the fact that there are many evidence connecting inadequate platelet inhibition with clinical outcomes in patients with acute coronary syndromes, the possible correlation between specific coronary angiographic factors and the rate of the inhibition has not been thoroughly investigated yet.Hypothesis: In the present study, we hypothesized that in patients with ST-elevation myocardial infarction (STEMI), greater intracoronary thrombus burden is connected with lower platelet inhibition after clopidogrel loading. Furthermore, the level of platelet inhibition is correlated with myocardial and coronary reperfusion after intervention, as well as with long-term clinical prognosis.Methods: Consecutive patients who underwent a late primary PCI (>2h FMC-balloon) were considered eligible for the study. Residual platelet reactivity was measured with the VerifyNow point of care assay and expressed in PRU. The intracoronary thrombus burden was evaluated and categorized (Grade A, B και C), as well as the coronary flow (TIMI flow) and the myocardial perfusion (Myocardial blush). Finally, long-term follow-up was conducted and major clinical events were recorded (death, myocardial infarction, vascular cerebral event, coronary revascularization).Results: 320 patients were initially considered eligible for the study. 74 patients who met the study criteria were finally included in the study and analyzed (81% male, mean age 60.9±11.9). It was found that patients with greater intracoronary thrombus burden, have statistically significant lower platelet inhibition (expressed in higher PRU levels - PRU=174.1±91.5 for thrombus Grade A, PRU=196.23±113.4 for Grade B and PRU=252.8±107.8 for Grade C, p=0.044) with significant PRU increasing linear trend along with increasing thrombus burden. Levels of PRU > 251.5 seem to predict the presence of large thrombus burden (Grade C) with a sensitivity of 57.9% and specificity of 77.8%. Furthermore, patients with normal coronary flow and normal myocardial perfusion after PCI, have statistically significant lower PRU levels related to those with impaired flow and perfusion respectively. Finally, during long-term follow-up (33±19months), the group of patients with increased residual platelet reactivity (PRU > 251.5), had a statistically significant increased rate of major clinical events, in comparison to the group of decreased residual reactivity (PRU<251.5) (p=0.043).Conclusions: It seem that among patients who undergo an unexpected delayed primary PCI, due to STEMI, those with higher PRU values (high residual platelet reactivity), manifest greater intracoronary thrombus burden, worst coronary flow and worst myocardial perfusion after PCI, with cut-off values of PRU > 251.5. Finally, patients with PRU levels above 251.5, have greater rates of long-term major clinical events.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalogeras, Konstantinos
- Καλογερἀς, Κωνσταντίνος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42658